NPM::ALK-STAT3 signaling in ALK+ ALCL induces expression of transforming growth factor beta (TGF-β), IL-10, and cell surface receptor PD-L1 (CD274, B7H1), creating an immunosuppressive tumor microenvironment (88). The gene discussed is ALK; the disease is neoplasm.